Identity Profiling of Complex Mixtures of Peptide Products by Structural and Mass Mobility Orthogonal Analysis.SHOW MORE
UDIBI admin_udibi3, 15 de March de 202215 de March de 2022, Uncategorized, 0 Development and validation of a mass spectrometric method to determine the identity of rituximab based on its microheterogeneity profile....
UDIBI admin_udibi3, 15 de March de 202215 de March de 2022, Uncategorized, 0 The yin/yang of inflammatory status: Blood-brain barrier regulation during sleep. SHOW MORE
UDIBI admin_udibi3, 15 de March de 202215 de March de 2022, Uncategorized, 0 Transferon in 2020 SHOW MORE
UDIBI admin_udibi3, 15 de March de 202215 de March de 2022, Uncategorized, 0 Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®). SHOW MORE
+ UDIBI admin_udibi3, 1 de June de 20231 de June de 2023, Uncategorized, 0 Published: September, 2019 A differential sex-specific pattern of IgG2 and IgG4 subclasses of anti-drug antibodies (ADAs) induced by glatiramer...
UDIBI admin_udibi3, 15 de March de 202215 de March de 2022, Uncategorized, 0 CD80 Expression Correlates with IL-6 Production in THP-1-Like Macrophages Costimulated with LPS and Dialyzable Leukocyte Extract (Transferon®). SHOW MORE
UDIBI admin_udibi3, 15 de March de 202215 de March de 2022, Uncategorized, 0 Validation of a cell proliferation assay to assess the potency of a Dialyzable Leucocyte Extract intended for batch release....
+ UDIBI admin_udibi3, 29 de August de 202329 de August de 2023, 2023, Uncategorized, 0 Efficacy, Pharmacokinetics, and Toxicity Profiles of Broad Anti-SARS-CoV-2 Neutralizing Antibody. SHOW MORE